Apellis Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
06 Apr 2026	Form 3: Biogen Inc., See footnotes Holds 0 shares of Common Stock
03 Mar 2026	Form 3: Dolsten Mikael, Director No securities owned
02 Sep 2025	Form 3: Meltzer Leslie, Chief Research and Development No securities owned
29 May 2025	Form 3: Boucher Kelley, Chief People Officer No securities owned
21 Apr 2025	Form 3: Wheeler Craig A, Director No securities owned
10 Jan 2025	Form 3: Walbert Keli, Director No securities owned
09 Jan 2023	Form 3: Baumal Caroline, Chief Medical Officer Holds 133.37 shares of Common Stock
05 Jan 2023	Form 3: Baumal Caroline, Chief Medical Officer Holds 133.37 shares of Common Stock
01 Sep 2021	Form 3: Chopas James George, See Remarks No securities owned
09 Apr 2021	Form 3: DeLong Mark Jeffrey, Senior Vice President Holds 8,698 shares of Common Stock
06 Oct 2020	Form 3: Nicholson Nur, Chief Technical Officer
06 Oct 2020	Form 3: Eisele Jeffrey, See Remarks
09 Jun 2020	Form 3: Lewis Karen, Chief People Officer
27 Apr 2020	Form 3: Brown Victoria L., Program Team Lead Holds 3,125 shares of Common Stock
06 Apr 2020	Form 3: Fonteyne Paul R., Director No securities owned
06 Aug 2019	Form 3: Celona Lucia, See Remarks
15 Apr 2019	Form 3: Townsend Adam J., See Remarks
15 Apr 2019	Form 3: Lackner Thomas A., See Remarks Holds 5,000 shares of Common Stock
15 Apr 2019	Form 3: Sadr Ahmad, See Remarks
17 Apr 2018	Form 3: Scheibler Lukas, See Remarks Holds 0 shares of No securities are beneficially owned

Comments